Literature DB >> 19930736

[An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].

Joan Doornebal1, Rina Bijlsma, René M L Brouwer.   

Abstract

Long-term use of proton pump inhibitors can lead to serious hypomagnesaemia. Intestinal magnesium absorption takes place by passive paracellular and active transcellular transport. It has been hypothesized that proton pump inhibitors impair the active transcellular magnesium transport. The resulting hypomagnesaemia may cause hypoparathyroidism, hypocalcaemia and hypokalaemia. Proton pump inhibitor-induced hypomagnesaemia is reversible: it resolves when proton pump inhibitors are stopped. The indication for long-term proton pump inhibitor treatment should be evaluated periodically.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19930736

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  8 in total

Review 1.  Adverse effects of long-term proton pump inhibitor therapy.

Authors:  Edward Sheen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

2.  Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.

Authors:  Ioannis Koulouridis; Mansour Alfayez; Hocine Tighiouart; Nicolaos E Madias; David M Kent; Jessica K Paulus; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2013-05-10       Impact factor: 8.860

3.  Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6.

Authors:  A L L Lameris; M W Hess; I van Kruijsbergen; J G J Hoenderop; R J M Bindels
Journal:  Pflugers Arch       Date:  2013-06-12       Impact factor: 3.657

4.  Severe hypocalcaemia and hypomagnesemia presenting with severe neurologic and gastro-intestinal symptoms: a case report and review of literature.

Authors:  F J de Boer; I van Ieperen; H E Boersma; H R Bouma
Journal:  CJEM       Date:  2021-02-05       Impact factor: 2.410

Review 5.  Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors.

Authors:  Simone Janett; Pietro Camozzi; Gabriëlla G A M Peeters; Sebastiano A G Lava; Giacomo D Simonetti; Barbara Goeggel Simonetti; Mario G Bianchetti; Gregorio P Milani
Journal:  Gastroenterol Res Pract       Date:  2015-05-04       Impact factor: 2.260

6.  A patient on long-term proton pump inhibitors develops sudden seizures and encephalopathy: an unusual presentation of hypomagnesaemia.

Authors:  Nirav Y Gandhi; Walid K Sharif; Sumeet Chadha; Jayadave Shakher
Journal:  Case Rep Gastrointest Med       Date:  2012-11-18

7.  Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System.

Authors:  Takao Tamura; Toshiyuki Sakaeda; Kaori Kadoyama; Yasushi Okuno
Journal:  Int J Med Sci       Date:  2012-06-13       Impact factor: 3.738

8.  Berberine protects against esophageal mucosal damage in reflux esophagitis by suppressing proinflammatory cytokines.

Authors:  Byung Kil Choo; Seong-Soo Roh
Journal:  Exp Ther Med       Date:  2013-07-04       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.